Saltar al contenido
Merck

1462006

USP

Nicotinamide

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

Nicotinamide, Niacinamide, Nicotinic acid amide, Pyridine-3-carboxylic acid amide, Vitamin B3, Vitamin PP

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C6H6N2O
Número CAS:
98-92-0
Peso molecular:
122.12
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
329750553
MDL number:
MFCD00006395
Beilstein/REAXYS Number:
383619

Nombre del producto

Nicotinamide, United States Pharmacopeia (USP) Reference Standard

InChI key

DFPAKSUCGFBDDF-UHFFFAOYSA-N

SMILES string

NC(=O)c1cccnc1

InChI

1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)

grade

pharmaceutical primary standard

API family

nicotinamide

manufacturer/tradename

USP

mp

128-131 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Niacinamide USP reference standard for use in specified quality tests and assays.

Also used to prepare standard, Niacin standard solution, standard niacinamide stock solution, and sample solution for assay, performance, and strength analysis according to the given below monographs and general chapters of United States Pharmacopeia (USP):
  • Niacinamide
  • Niacinamide Tablets
  • Niacinamide Injection
  • 〈441〉 Niacin or Niacinamide Assay

Biochem/physiol Actions

Nicotinamide is an amide derivative of vitamin B3 and a PARP inhibitor

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H319

Hazard Classifications

Eye Irrit. 2

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 1

flash_point_f

302.0 °F - closed cup

flash_point_c

150 °C - closed cup

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Niacinamide Tablets
United States Pharmacopeia, 30(1), 3147-3147 (2020)
Niacinamide Injection
United States Pharmacopeia, 46(5) (2023)
Niacinamide
United States Pharmacopeia, 34(5), 3146-3146 (2020)
441 Niacin or Niacinamide Assay
United States Pharmacopeia, 39(5), 6704-6704 (2014)
Mitchell E Horwitz et al.
The Journal of clinical investigation, 124(7), 3121-3128 (2014-06-10)
Delayed hematopoietic recovery is a major drawback of umbilical cord blood (UCB) transplantation. Transplantation of ex vivo-expanded UCB shortens time to hematopoietic recovery, but long-term, robust engraftment by the expanded unit has yet to be demonstrated. We tested the hypothesis
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico